Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Urinary phenylacetate and response to methylphenidate.

L R Baxter1, R C Kelly, J B Peter

  • 1Department of Psychiatry and Biobehavioral Science, UCLA School of Medicine 90024.

Journal of Psychiatric Research
|January 1, 1988
PubMed
Summary

Phenylacetate (PAA) levels did not significantly differ between depressed patients and controls. However, PAA excretion variance was higher in depressed individuals, with some showing exceptionally low levels, suggesting a potential link to mood response in depression.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sex, population, and the physician.

Journal of religion and health·2014
Same author

Frequency stabilization of a high power argon laser.

Applied optics·2010
Same author

The 'rule out lupus' rheumatology consultation: clinical outcomes and perspectives.

Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases·2008
Same author

Risk factors for subclinical atherosclerosis in a prospective cohort of patients with systemic lupus erythematosus.

Annals of the rheumatic diseases·2003
Same author

Solution-mediated phase transformation of anhydrous to dihydrate carbamazepine and the effect of lattice disorder.

International journal of pharmaceutics·2002
Same author

In vitro antiviral and antibacterial activity of commercial intravenous immunoglobulin preparations--a potential role for adjuvant intravenous immunoglobulin therapy in infectious diseases.

Transfusion medicine (Oxford, England)·2002

Area of Science:

  • Neuroscience
  • Biochemistry
  • Psychiatry

Background:

  • Phenylacetate (PAA) is a metabolite of phenylalanine and phenylethylamine.
  • PAA has been previously reported to be low in unipolar depression.
  • Phenylethylamine is involved in the actions of stimulant medications.

Purpose of the Study:

  • To investigate 24-hour urinary PAA excretion in unipolar depression.
  • To examine the relationship between PAA levels, dexamethasone suppression test (DST) results, and methylphenidate response in depressed patients.

Main Methods:

  • Measured 24-hour urinary PAA in 21 normal controls and 33 unipolar depression inpatients (12 drug-free).
  • Performed dexamethasone suppression tests (DST) on participants.
  • Administered methylphenidate challenges to assess mood response in patients.

Related Experiment Videos

Main Results:

  • No significant difference in mean 24-hour urinary PAA excretion between depressed patients and controls (P > 0.9).
  • Higher variance in PAA excretion observed in depressed patients compared to controls.
  • Five depressed patients exhibited PAA levels at or above the 99% confidence limit for normal controls.
  • No association found between DST results and PAA excretion (P > 0.4).
  • Patients experiencing mood worsening after methylphenidate challenge excreted less PAA than those with mood improvement (P < 0.025).

Conclusions:

  • While mean PAA levels may not differ, altered PAA excretion patterns (higher variance, some very low values) are present in unipolar depression.
  • PAA excretion may correlate with stimulant response, specifically methylphenidate-induced mood changes.
  • Further research is warranted to elucidate the clinical and theoretical significance of PAA in depression and its modulation by medication.